Amy Garabedian
Consigliere Generale presso LAVA THERAPEUTICS N.V.
Patrimonio netto: 152 548 $ in data 31/05/2024
Profilo
Amy Garabedian is currently the Secretary & General Counsel at LAVA Therapeutics NV since 2021.
Prior to this, she worked as an Attorney at Ballard Spahr LLP.
From 2015 to 2020, she worked as an Associate General Counsel at Spark Therapeutics, Inc. Ms. Garabedian has a graduate degree from Temple University (Pennsylvania) and Widener University Delaware Law School, and an undergraduate degree from The Pennsylvania State University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
LAVA THERAPEUTICS NV
0.26% | 28/02/2023 | 67 499 ( 0.26% ) | 152 548 $ | 31/05/2024 |
Posizioni attive di Amy Garabedian
Società | Posizione | Inizio |
---|---|---|
LAVA THERAPEUTICS N.V. | Consigliere Generale | 27/07/2021 |
Precedenti posizioni note di Amy Garabedian
Società | Posizione | Fine |
---|---|---|
SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2020 |
Ballard Spahr LLP
Ballard Spahr LLP Miscellaneous Commercial ServicesCommercial Services Ballard Spahr LLP provides legal services. It also provides counsel in litigation, business and finance, real estate, intellectual property, and public finance. The company was founded in 1885 and is headquartered in Philadelphia, PA. | Consigliere Generale | - |
Formazione di Amy Garabedian
The Pennsylvania State University | Undergraduate Degree |
Temple University (Pennsylvania) | Graduate Degree |
Widener University Delaware Law School | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
LAVA THERAPEUTICS N.V. | Health Technology |
Aziende private | 2 |
---|---|
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
Ballard Spahr LLP
Ballard Spahr LLP Miscellaneous Commercial ServicesCommercial Services Ballard Spahr LLP provides legal services. It also provides counsel in litigation, business and finance, real estate, intellectual property, and public finance. The company was founded in 1885 and is headquartered in Philadelphia, PA. | Commercial Services |
- Borsa valori
- Insiders
- Amy Garabedian